Sugi Holdings Co (STU:UGI) Research & Development: €0 Mil (TTM As of Feb. 2026)


STU:UGI Sugi Holdings Co Ltd STU:UGI
96 GF Score
Price €16.70
GF Value €18.36
! 4 Warning Signs
View Full Analysis

What is Sugi Holdings Co Research & Development?

Sugi Holdings Co STU:UGI +3.09% 96 Research & Development is €0 Mil as of Feb. 2026. GuruFocus rates STU:UGI with a GF Score™ of 96/100 and a GF Value™ of €18.36. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sugi Holdings Co's Research & Development for the three months ended in Feb. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was €0 Mil.

Sugi Holdings Co  (STU:UGI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sugi Holdings Co Research & Development Related Terms

Sugi Holdings Co Research & Development Historical Data

* Premium members only.

The historical data trend for Sugi Holdings Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sugi Holdings Co Research & Development Chart

Sugi Holdings Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sugi Holdings Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:UGI
96GF Score
Sugi Holdings Co Ltd STU:UGI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sugi Holdings Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Sugi Holdings Co (STU:UGI) has a Research & Development of €0 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on Sugi Holdings Co and its competitors.
Is Sugi Holdings Co's Research & Development too high?
Sugi Holdings Co's current Research & Development is €0 Mil. Overall, Sugi Holdings Co has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does Sugi Holdings Co's Research & Development compare to competitors?
Sugi Holdings Co's Research & Development of €0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sugi Holdings Co and its competitors. Sugi Holdings Co's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sugi Holdings Co stock overvalued right now?
Sugi Holdings Co (STU:UGI) has a current Research & Development of €0 Mil. The stock's GF Value™ is €18.36, compared to a current price of €16.70 — trading 9% below its estimated fair value. The current Research & Development is €0 Mil. Sugi Holdings Co's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sugi Holdings Co (STU:UGI), the current Research & Development is €0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sugi Holdings Co (STU:UGI) Overvalued in 2026?

Based on GuruFocus' analysis, Sugi Holdings Co stock appears to be undervalued. The current stock price of €16.70 is trading 9% below its estimated GF Value™ of €18.36.

Key valuation signals for STU:UGI:

  • Research & Development: €0 Mil
  • GF Value™: €18.36 vs. price of €16.70 (9% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the STU:UGI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sugi Holdings Co Business Description

Other Exchanges 7649:JapanUGI:Germany
Address 62-1 Shine, Yokone-cho, Aichi Prefecture, Obu, JPN, 474-0011
Sugi Holdings Co Ltd is a Japan-based company engaged in drugstore operations and the pharmaceutical dispensing business. Through its subsidiaries, the company is involved in selling pharmaceuticals, health foods, cosmetics, daily essentials, and prescription drugs. It also operates community-based drugstores that support home healthcare in collaboration with local medical professionals. The company also supports regional healthcare facilities and provides at-home nursing services.
96GF Score

Get the complete analysis for STU:UGI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.70
Price
€18.36
GF Value